Market Capitalization of Dr Lalchandani Labs (DLCL)
Dr Lalchandani Labs (DLCL) is a Healthcare Services sector company. Live share price data is currently unavailable, however you can explore DLCL financial statements, balance sheet and fundamentals below. Log your investment research and trade decisions in Tickjournal's free trading journal. Read DLCL dividend growth for the complete payout history and dividend yield track record.
Stock Price Data Not Available
Historical market capitalization trends require stock price information, which is currently not available for Dr Lalchandani Labs (DLCL). However, you can explore comprehensive financial statements and data for this company below.
Income Statement Summary - Dr Lalchandani Labs
Revenue, profitability, and earnings data (9 periods of data available)
| Period | Revenue | EBITDA | Operating Profit | Net Profit | EPS | Operating Margin |
|---|---|---|---|---|---|---|
| None | ₹0.0 Cr | ₹0.0 Cr | ₹0.0 Cr | ₹0.0 Cr | ₹0.0 | 0.0% |
| March 2025 | ₹5.0 Cr | ₹1.0 Cr | ₹0.0 Cr | ₹0.0 Cr | ₹0.96 | 21.0% |
| March 2024 | ₹5.0 Cr | ₹0.0 Cr | ₹-1.0 Cr | ₹1.0 Cr | ₹1.43 | 4.0% |
| March 2023 | ₹5.0 Cr | ₹0.0 Cr | ₹-1.0 Cr | ₹-2.0 Cr | ₹-3.61 | 2.0% |
| March 2022 | ₹11.0 Cr | ₹2.0 Cr | ₹1.0 Cr | ₹1.0 Cr | ₹2.15 | 21.0% |
| March 2021 | ₹10.0 Cr | ₹2.0 Cr | ₹1.0 Cr | ₹1.0 Cr | ₹2.33 | 23.0% |
| March 2020 | ₹6.0 Cr | ₹1.0 Cr | ₹1.0 Cr | ₹1.0 Cr | ₹1.09 | 21.0% |
| March 2019 | ₹5.0 Cr | ₹1.0 Cr | ₹1.0 Cr | ₹1.0 Cr | ₹1.23 | 23.0% |
| March 2018 | ₹3.0 Cr | ₹1.0 Cr | ₹1.0 Cr | ₹0.0 Cr | ₹0.89 | 22.0% |
Balance Sheet Summary - Dr Lalchandani Labs
Assets, liabilities, and equity data (8 years of data available)
| Year | Total Assets | Fixed Assets | Current Assets | Total Equity | Total Liabilities | Current Liabilities | Current Ratio |
|---|---|---|---|---|---|---|---|
| 2025 | ₹16.0 Cr | ₹4.0 Cr | ₹11.0 Cr | ₹10.0 Cr | - | ₹0.0 Cr | - |
| 2024 | ₹15.0 Cr | ₹4.0 Cr | ₹10.0 Cr | ₹10.0 Cr | - | ₹0.0 Cr | - |
| 2023 | ₹18.0 Cr | ₹5.0 Cr | ₹11.0 Cr | ₹9.0 Cr | - | ₹4.0 Cr | 2.75 |
| 2022 | ₹18.0 Cr | ₹6.0 Cr | ₹11.0 Cr | ₹11.0 Cr | - | ₹3.0 Cr | 3.67 |
| 2021 | ₹15.0 Cr | ₹5.0 Cr | ₹9.0 Cr | ₹10.0 Cr | - | ₹3.0 Cr | 3.0 |
| 2020 | ₹12.0 Cr | ₹4.0 Cr | ₹8.0 Cr | ₹9.0 Cr | - | ₹2.0 Cr | 4.0 |
| 2019 | ₹10.0 Cr | ₹3.0 Cr | ₹6.0 Cr | ₹8.0 Cr | - | ₹1.0 Cr | 6.0 |
| 2018 | ₹6.0 Cr | ₹2.0 Cr | ₹4.0 Cr | ₹3.0 Cr | - | ₹1.0 Cr | 4.0 |
Cash Flow Statement - Dr Lalchandani Labs
Operating, investing, and financing cash flows (8 periods of data available)
| Period | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Flow |
|---|---|---|---|---|
| March 2025 | ₹0.0 Cr | ₹0.0 Cr | ₹1.0 Cr | ₹1.0 Cr |
| March 2024 | ₹0.0 Cr | ₹1.0 Cr | ₹-2.0 Cr | ₹-1.0 Cr |
| March 2023 | ₹0.0 Cr | ₹0.0 Cr | ₹0.0 Cr | ₹0.0 Cr |
| March 2022 | ₹2.0 Cr | ₹-2.0 Cr | ₹0.0 Cr | ₹1.0 Cr |
| March 2021 | ₹1.0 Cr | ₹-2.0 Cr | ₹2.0 Cr | ₹1.0 Cr |
| March 2020 | ₹0.0 Cr | ₹-1.0 Cr | ₹1.0 Cr | ₹0.0 Cr |
| March 2019 | ₹0.0 Cr | ₹-2.0 Cr | ₹4.0 Cr | ₹1.0 Cr |
| March 2018 | ₹1.0 Cr | ₹-1.0 Cr | ₹2.0 Cr | ₹1.0 Cr |
About Market Capitalization
Why is market cap important?
Market capitalization represents the total market value of a company's outstanding shares. It helps investors assess company size, compare valuations across sectors, and make informed portfolio allocation decisions. For live price, earnings and the complete company profile, see Dr Lalchandani Labs share price chart.
- Assess company size and investment risk
- Compare companies across sectors
- Track valuation trends over time
- Make informed portfolio allocation decisions
What happens when price data is unavailable?
While we cannot show historical market cap trends without stock price data, you can still assess the company's financial strength using metrics like revenue, profitability, debt ratios, and asset values shown in the financial statements above. Analyse DLCL institutional holdings to track promoter, FII and institutional holdings.